Free Trial
CVE:SCA

Savary Gold (SCA) Stock Price, News & Analysis

C$0.12 -0.01 (-4.17%)
As of 05/2/2019

About Savary Gold Stock (CVE:SCA)

Key Stats

Today's Range
C$0.12
C$0.12
50-Day Range
C$0.12
C$0.12
52-Week Range
C$0.04
C$0.13
Volume
204,500 shs
Average Volume
830,838 shs
Market Capitalization
C$29.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Savary Gold Corp. engages in the exploration and evaluation of gold properties in West Africa. Its principal project is the Karankasso project that consists of five exploration licenses covering a total area of 688 square kilometers located in the Houndé Gold Belt in Burkina Faso. The company was formerly known as Savary Capital Corp. and changed its name to Savary Gold Corp. in September 2012. Savary Gold Corp. was incorporated in 2008 and is headquartered in Toronto, Canada.

Receive SCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Savary Gold and its competitors with MarketBeat's FREE daily newsletter.

SCA Stock News Headlines

Spinnaker SCA Acquires Accelogix
See More Headlines

SCA Stock Analysis - Frequently Asked Questions

Savary Gold's stock was trading at C$0.12 at the beginning of 2025. Since then, SCA stock has increased by 0.0% and is now trading at C$0.12.
View the best growth stocks for 2025 here
.

Shares of SCA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Savary Gold investors own include SLR Investment (SLRC), Saul Centers (BFS), Virtus LifeSci Biotech Products ETF (BBP), Bellevue Healthcare (BBH), Virtus LifeSci Biotech Clinical Trials ETF (BBC), ArrowMark Financial (BANX) and Yamana Gold (AUY).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Gold
Sub-Industry
N/A
Current Symbol
CVE:SCA
CIK
N/A
Fax
N/A
Employees
1,228
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.01 per share
Price / Cash Flow
14.38
Book Value
C$0.05 per share
Price / Book
2.21

Miscellaneous

Free Float
N/A
Market Cap
C$29.40 million
Optionable
Not Optionable
Beta
N/A

This page (CVE:SCA) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners